17-47283544-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PP4_StrongPP3

This summary comes from the ClinGen Evidence Repository: The NM_000212.3(ITGB3):c.356G>A variant predicts a missense change, Arg119Gln. It is reported at a frequency of 0.0001468 (11/74914 alleles) in the gnomAD v4.0.0 African/African-American population, above the <0.0001 threshold for PM2_Supporting. At least 4 GT patients (homozygous and compound heterozygous) with the variant have been reported in the literature (PMIDs: 19691478, 16463284, 25728920). The proband from PMID:25728920 meets criteria for PP4_Strong including bleeding phenotype, abnormal platelet aggregation in response to >2 agonists and normal aggregation to ristocetin, reduced αIIbβ3 integrin expression on flow cytometry and full sequencing of ITGA2B and ITGB3 both genes. The variant has a REVEL score of 0.936, meeting criteria for PP3 (threshold: >0.7). In summary, there is insufficient evidence at this time to classify the Arg119Gln variant. GT-specific criteria met: PP3, PP4_strong. LINK:https://erepo.genome.network/evrepo/ui/classification/CA8622925/MONDO:0010119/011

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000016 ( 0 hom. )

Consequence

ITGB3
NM_000212.3 missense

Scores

12
4
2

Clinical Significance

Uncertain significance reviewed by expert panel P:1U:1

Conservation

PhyloP100: 9.42
Variant links:
Genes affected
ITGB3 (HGNC:6156): (integrin subunit beta 3) The ITGB3 protein product is the integrin beta chain beta 3. Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain. A given chain may combine with multiple partners resulting in different integrins. Integrin beta 3 is found along with the alpha IIb chain in platelets. Integrins are known to participate in cell adhesion as well as cell-surface mediated signalling. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 5 ACMG points.

PP3
For more information check the summary or visit ClinGen Evidence Repository.
PP4
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ITGB3NM_000212.3 linkuse as main transcriptc.356G>A p.Arg119Gln missense_variant 3/15 ENST00000559488.7 NP_000203.2 P05106-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ITGB3ENST00000559488.7 linkuse as main transcriptc.356G>A p.Arg119Gln missense_variant 3/151 NM_000212.3 ENSP00000452786.2 P05106-1
ITGB3ENST00000571680.1 linkuse as main transcriptc.356G>A p.Arg119Gln missense_variant 3/91 ENSP00000461626.1 I3L4X8
ENSG00000259753ENST00000560629.1 linkuse as main transcriptn.320G>A non_coding_transcript_exon_variant 3/182 ENSP00000456711.2 H3BM21
ITGB3ENST00000696963.1 linkuse as main transcriptc.356G>A p.Arg119Gln missense_variant 3/14 ENSP00000513002.1 P05106-2

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152188
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.0000160
AC:
4
AN:
249610
Hom.:
0
AF XY:
0.00000740
AC XY:
1
AN XY:
135108
show subpopulations
Gnomad AFR exome
AF:
0.000247
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000164
AC:
24
AN:
1461844
Hom.:
0
Cov.:
33
AF XY:
0.0000124
AC XY:
9
AN XY:
727232
show subpopulations
Gnomad4 AFR exome
AF:
0.000209
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000144
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000526
AC:
8
AN:
152188
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74352
show subpopulations
Gnomad4 AFR
AF:
0.0000965
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.0000942
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.000187
Hom.:
0
Bravo
AF:
0.0000945
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 12, 2023This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 119 of the ITGB3 protein (p.Arg119Gln). This variant is present in population databases (rs147782061, gnomAD 0.03%). This missense change has been observed in individuals with autosomal recessive Glanzmann thrombasthenia (PMID: 16463284, 19691478, 25728920). ClinVar contains an entry for this variant (Variation ID: 996208). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ITGB3 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
Glanzmann thrombasthenia Uncertain:1
Uncertain significance, reviewed by expert panelcurationClinGen Platelet Disorders Variant Curation Expert Panel, ClinGenNov 02, 2023The NM_000212.3(ITGB3):c.356G>A variant predicts a missense change, Arg119Gln. It is reported at a frequency of 0.0001468 (11/74914 alleles) in the gnomAD v4.0.0 African/African-American population, above the <0.0001 threshold for PM2_Supporting. At least 4 GT patients (homozygous and compound heterozygous) with the variant have been reported in the literature (PMIDs: 19691478, 16463284, 25728920). The proband from PMID: 25728920 meets criteria for PP4_Strong including bleeding phenotype, abnormal platelet aggregation in response to >2 agonists and normal aggregation to ristocetin, reduced αIIbβ3 integrin expression on flow cytometry and full sequencing of ITGA2B and ITGB3 both genes. The variant has a REVEL score of 0.936, meeting criteria for PP3 (threshold: >0.7). In summary, there is insufficient evidence at this time to classify the Arg119Gln variant. GT-specific criteria met: PP3, PP4_strong. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.70
BayesDel_addAF
Pathogenic
0.33
D
BayesDel_noAF
Pathogenic
0.54
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.97
D;.
Eigen
Pathogenic
0.97
Eigen_PC
Pathogenic
0.95
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.97
D;D
M_CAP
Pathogenic
0.41
D
MetaRNN
Pathogenic
0.95
D;D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Pathogenic
3.9
H;.
PrimateAI
Benign
0.41
T
PROVEAN
Uncertain
-3.8
D;.
Sift
Uncertain
0.0010
D;.
Sift4G
Uncertain
0.016
D;D
Polyphen
0.98
D;.
Vest4
0.92
MVP
0.98
MPC
1.3
ClinPred
1.0
D
GERP RS
5.9
Varity_R
0.77
gMVP
0.87

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147782061; hg19: chr17-45360910; COSMIC: COSV101457615; COSMIC: COSV101457615; API